ARTL Stock Analysis: Buy, Sell, or Hold?
ARTL - Artelo Biosciences, Inc. Common Stock
$6.36
5.70 (859.71%)
▲
5d:
+823.08%
30d:
+725.97%
90d:
+344.76%
WAIT
LOW Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When ARTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ARTL is 233.0% above its trading range ($1.91). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ARTL is 233.0% above its trading range ($1.91). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ARTL is currently trading at $6.36, which is considered extended relative to its 30-day fair value range of $-0.01 to $1.91.
Technical Outlook: Technically, ARTL is in a strong downtrend. Immediate support is located at $0.52, while resistance sits at $6.79. The stock is showing strong short-term momentum, up 859.7% recently.
Market Sentiment: ARTL scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.00 (+183.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTL is in a strong downtrend. Immediate support is located at $0.52, while resistance sits at $6.79. The stock is showing strong short-term momentum, up 859.7% recently.
Market Sentiment: ARTL scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.00 (+183.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.01 -
$1.91
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price significantly overextended (+233.0% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+859.7%)
- BULLISH: Trading 183.0% below Wall St target ($18.00)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.01 -
$1.91
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.52
Resistance Level
$6.79
Current Trend
Strong Downtrend
Technical data as of
Aug 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.20
Wall Street Target
$18.00
(+183.0%)
Share & Embed Analysis
Last updated: August 31, 2026 7:43 PM ET
Data refreshes hourly during market hours. Next update: 8:43 PM
Data refreshes hourly during market hours. Next update: 8:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1176 | 42 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$840 | 41 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$287 | 59 HOLD |
